Types of Melanoma Research Funding

The MRF's 2017 Request for Proposals is now available!

Applications are submitted and managed entirely online through ProposalCENTRAL and are only available during the application cycle (Jan. 1 - March 1). 

All proposals will undergo a rigorous peer-reviewed process by hand-selected experts in diverse areas of melanoma research. Proposals with the highest scores and with discrepant scores are then reviewed a second time by the MRF's Scientific Advisory Committee (SAC) and final decisions are made by the MRF's Board of Directors.

Learn about previously funded MRF research by visiting our Research Recipients page!

Team Awards

Team Awards will not be accepted in 2017 but will be accepted again in 2018. Team Awards provide funding of up to $250,000 per year for two years. Please review the 2017 Request for Proposals to learn more about the Team Awards and expectations for 2018.

Established Investigator Awards (EIA)

The EIAs provide funding of up to $100,000 per year for two years to established melanoma researchers, or senior researchers working in closely related fields who wish to move into melanoma research. The use of relevant genetic models and human derived tumor samples is highly encouraged. EIA applications are encouraged, but not required, to be part of the STP mechanism listed below.

Career Development Awards (CDA)

The CDAs provide funding of up to $50,000 per year for two years to junior investigators. Researchers who are beginning a research career focused on melanoma and have not yet established strong federal funding for their research are eligible. The use of relevant genetic models and human derived tumor samples is highly encouraged. CDA applications are encouraged, but not required, to be part of the STP mechanism listed below.

*In 2017, we have funding to support at least one grant specific to resistance to BRAF and MEK inhibition. 

Specific Topic Proposals

The identification of scientific topics that address unmet clinical needs in melanoma research were identified through a series of meetings of multidisciplinary experts from the MRF’s Scientific Advisory Committee and Breakthrough Consortium Steering Committee. The following categories are the identified unmet needs in melanoma research selected as STPs for 2015. 

  • Prevention: Development of models and biomarkers
  • Identifying mechanisms and respective therapeutic strategies in less common molecular subsets of melanoma
  • Metastases: Dormancy and metastatic progression
  • CNS Metastases: Development of markers of risk and rational therapeutic approaches
  • Response to Treatment: Mechanisms and respective biomarkers for predicting response and for monitoring therapeutic response
  • Resistance: Intrinsic/Innate/Primary resistance to immunotherapies in melanoma

Please refer to the 2017 RFP for a full definition of each STP. Career Development and Established Investigator applicants are encouraged, but not required, to focus on one of these themes in their proposals. Team Award applications are required to focus on one of the STPs.

Learn how to apply for a MRF research grant.

Medical Student Awards

The 2017 Medical Student Grants are now under review. 

The MRF's Medical Student Award Program provides one-year awards of up to $3,000 for medical students to engage in short clinical or laboratory-based research projects focused on better understanding the biology and treatment of melanoma. All proposals will undergo a rigorous peer-reviewed process by hand-selected experts in diverse areas of melanoma research. 

Learn about previously funded MRF research by visiting our Research Recipients page!